BARD1 and esophageal cancer: Additionally, GSEA enrichments revealed the suppression of cell cycle and mitotic checkpoint regulatory (AURKB, PLK1, and E2F) and the DDR and DNA-repair (ATR, BARD1, and FANCONI) pathways by STL001 in esophageal cancer (Fig. 3D).